Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule
Adenoviral vectors are being developed as vaccines against infectious agents and tumour-associated antigens, because of their ability to induce cellular immunity. However, the protection afforded in animal models has not easily translated into primates and clinical trials, underlying the need for im...
| Κύριοι συγγραφείς: | , , , , , , , , |
|---|---|
| Μορφή: | Journal article |
| Γλώσσα: | English |
| Έκδοση: |
Springer Nature
2020
|